Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009

The Lancet Oncology

Volumn 10, Issue 11, 2009, Pages 1086-1092

  Wee, Joseph T ^a   Anderson, Benjamin O ^b   Corry, June ^c   D'Cruz, Anil ^d   Soo, Khee C ^a   Qian, Chao Nan ^e   Chua, Daniel T ^f   Hicks, Rodney J ^c   Goh, Christopher HK ^g   Khoo, James B ^a   Ong, Seng C ^h   Forastiere, Arlene A ⁱ   Chan, Anthony T ^j  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d TATA MEMORIAL HOSPITAL   (India)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

^g SINGAPORE GENERAL HOSPITAL   (Singapore)

^h MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ASIA; CANCER RECURRENCE; CANCER THERAPY; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; IMAGE DISPLAY; LYMPH NODE METASTASIS; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW;

ASIA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CONGRESSES AS TOPIC; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MEDICAL ONCOLOGY; NECK DISSECTION; PATIENT SELECTION; PHYSICAL EXAMINATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 71249160153     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70266-9     Document Type: Review

References (78)

1. Forastiere A.A., Ang K.K., Brizel D., et al. Head and neck cancers. J Natl Compr Canc Netw 6 (2008) 646-695
2. Armstrong J., Pfister D., Strong E., et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 26 (1993) 759-765
3. Peters L.J., Weber R.S., Morrison W.H., Byers R.M., Garden A.S., and Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 18 (1996) 552-559
4. Johnson C.R., Silverman L.N., Clay L.B., and Schmidt-Ullrich R. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary?. Radiat Oncol Investig 6 (1998) 52-57
5. Garden A.S., Glisson B.S., Ang K.K., et al. Phase 1-2 trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 17 (1999) 2390-2395
6. Robbins K.T., Wong F.S., Kumar P., et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125 (1999) 670-675
7. Ahmed K.A., Robbins K.T., Wong F., and Salazar J.E. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 110 (2000) 1789-1793
8. Corry J., Rischin D., Smith J.G., et al. Radiation with concurrent late chemotherapy intensification (chemoboost) for locally advanced head and neck cancer. Radiother Oncol 54 (2000) 123-127
9. Chan A.W., Ancukiewicz M., Carballo N., Montgomery W., and Wang C.C. The role of post radiotherapy neck dissection in supraglottic carcinoma. Int J Radiat Oncol Biol Phys 50 (2001) 367-375
10. Clayman G.L., Johnson II C.J., Morrison W., Ginsberg L., and Lippman S.M. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 127 (2001) 135-139
11. Grabenbauer G.G., Rödel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only?. Radiother Oncol 66 (2003) 57-63
12. Pletcher S.D., Kaplan M.J., Eisele D.W., Singer M.I., Quivey J.M., and Lee N. Management of cervical metastases in advanced squamous cell carcinoma of the base of tongue. Arch Otolaryngol Head Neck Surg 129 (2003) 983-986
13. Argiris A., Stenson K.M., Brockstein B.E., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 26 (2004) 447-455
14. Vongtama R., Lee M., Kim B., et al. Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation. Cancer J 10 (2004) 339-342
15. Yao M., Smith R.B., Graham M.M., et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 63 (2005) 991-999
16. Forest V.I., Nguyen-Tan P.F., Tabet J.C., et al. Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma. Head Neck 28 (2006) 1099-1105
17. Goguen L.A., Posner M.R., Tishler R.B., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 132 (2006) 526-531
18. Liauw S.L., Mancuso A.A., Amdur R.J., et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol 24 (2006) 1421-1427
19. Thariat J., Ahamad A., Garden A.S., et al. Prediction of neck dissection (ND) requirement following definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC). Int J Radiat Oncol Biol Phys 66 suppl 1 (2006) 17-18
20. Corry J., Peters L., Fisher R., et al. N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02. Head Neck 30 (2008) 737-742
21. Nayak J.V., Walvekar R.R., Andrade R.S., et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 117 (2007) 2129-2134
22. Lau H., Phan T., Mackinnon J., and Matthews T.W. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 134 (2008) 257-261
23. Rodríguez M.L., Padellano L.C., Martín M.M., and Lorenzo F.C. Neck dissection after radiochemotherapy in patients with loco regionally advanced head and neck cancer. Clin Transl Oncol 10 (2008) 812-816
24. Rengan R., Pfister D.G., Lee N.Y., et al. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol 31 (2008) 465-469
25. Vedrine P.O., Thariat J., Hitier M., et al. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope 118 (2008) 1775-1780
26. Mendenhall W.M., Million R.R., and Cassisi N.J. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12 (1986) 733-740
27. Boyd T.S., Harari P.M., Tannehill S.P., et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 20 (1998) 132-137
28. Roy S., Tibesar R.J., Daly K., et al. Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy. Head Neck 24 (2002) 474-481
29. Velázquez R.A., McGuff H.S., Sycamore D., and Miller F.R. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 130 (2004) 74-77
30. Stenson K.M., Huo D., Blair E., et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 116 (2006) 33-36
31. Sewall G.K., Palazzi-Churas K.L., Richards G.M., Hartig G.K., and Harari P.M. Planned postradiotherapy neck dissection: rationale and clinical outcomes. Laryngoscope 117 (2007) 121-128
32. Parsons J.T., Mendenhall W.M., Cassisi N.J., Stringer S.P., and Million R.R. Neck dissection after twice-a-day radiotherapy: morbidity and recurrence rates. Head Neck 11 (1989) 400-404
33. Lavertu P., Adelstein D.J., Saxton J.P., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19 (1997) 559-566
34. Lee H.J., Zelefsky M.J., Kraus D.H., et al. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys 38 (1997) 995-1000
35. Mendenhall W.M., Stringer S.P., Amdur R.J., Hinerman R.W., Moore-Higgs G.J., and Cassisi N.J. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?. J Clin Oncol 18 (2000) 35-42
36. Mendenhall W.M., Amdur R.J., Stringer S.P., Villaret D.B., and Cassisi N.J. Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery?. J Clin Oncol 18 (2000) 2219-2225
37. Wang S.J., Wang M.B., Yip H., and Calcaterra T.C. Combined radiotherapy with planned neck dissection for small head and neck cancers with advanced cervical metastases. Laryngoscope 110 (2000) 1794-1797
38. Newkirk K.A., Cullen K.J., Harter K.W., Picken C.A., Sessions R.B., and Davidson B.J. Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 23 (2001) 73-79
39. Somerset J.D., Mendenhall W.M., Amdur R.J., Villaret D.B., and Stringer S.P. Planned postradiotherapy bilateral neck dissection for head and neck cancer. Am J Otolaryngol 22 (2001) 383-386
40. Brizel D.M., Prosnitz R.G., Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1418-1423
41. Frank D.K., Hu K.S., Culliney B.E., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
42. Adelstein D.J., Saxton J.P., Rybicki L.A., et al. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 24 (2006) 1064-1071
43. Nouraei S.A., Upile T., Al-Yaghchi C., et al. Role of planned postchemoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 118 (2008) 797-803
44. Porceddu S.V., Jarmolowski E., Hicks R.J., et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 27 (2005) 175-181
45. Anderson B.O., Yip C.H., Smith R.A., et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 113 8 suppl (2008) 2221-2243
46. Liauw S.L., Amdur R.J., Morris C.G., Werning J.W., Villaret D.B., and Mendenhall W.M. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck 29 (2007) 715-719
47. Branstetter B.F., Blodgett T.M., Zimmer L.A., et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology 235 (2005) 580-586
48. Connell C.A., Corry J., Milner A.D., et al. Clinical impact of, and prognostic stratification by, F-18 FDG PET-CT in head and neck mucosal squamous cell carcinoma. Head Neck 29 (2007) 986-995
49. McHam S.A., Adelstein D.J., Rybicki L.A., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?. Head Neck 25 (2003) 791-798
50. Frank D.K., Hu K.S., Culliney B.E., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
51. Yeung A.R., Liauw S.L., Amdur R.J., et al. Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?. Cancer 112 (2008) 1076-1082
52. Greven K.M., Williams D.W., Browne J.D., McGuirt W.F., White D.R., and D'Agostino R.B. Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Am J Clin Oncol 31 (2008) 169-172
53. Richards P.S., and Peacock T.E. The role of ultrasound in the detection of cervical lymph node metastases in clinically N0 squamous cell carcinoma of the head and neck. Cancer Imaging 7 (2007) 167-178
54. Sumi M., Ohki M., and Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 176 (2001) 1019-1024
55. Brizel D.M., and Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 24 (2006) 2612-2617
56. Temam S., Pape E., Janot F., et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62 (2005) 1078-1083
57. Robbins K.T., Doweck I., Samant S., and Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after CRT. Arch Otolaryngol Head Neck Surg 131 (2005) 965-969
58. Robbins K.T., Shannon K., and Vieira F. Superselective neck dissection after chemoradiation. Arch Otolaryngol Head Neck Surg 133 (2007) 486-489
59. Mukhija V., Gupta S., Jacobson A.S., Eloy J.A., and Genden E.M. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck 31 (2009) 183-188
60. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126 (2000) 950-956
61. Frank D.K., Hu K.S., Culliney B.E., et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope 115 (2005) 1015-1020
62. de Bondt R.B., Nelemans P.J., Hofman P.A., et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USg FNAC, CT and MR imaging. Eur J Radiol 64 (2007) 266-272
63. Vandecaveye V., De Keyzer F., and Hermans R. Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy. Cancer Imaging 8 (2008) 173-180
64. Moreau P., Goffart Y., and Collingnon J. Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 116 (1990) 1190-1193
65. van den Brekel M.W., Stel H.V., Castelijns J.A., et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177 (1990) 379-384
66. Som P.M. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 158 (1992) 961-969
67. Inohara H., Enomoto K., Tomiyama Y., et al. The role of CT and (18)F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol 7 (2008) 1-7
68. Tan A., Adelstein D.J., Rybicki L.A., et al. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Arch Otolaryngol Head Neck Surg 133 (2007) 435-440
69. Liauw S.L., Mancuso A.A., Morris C.G., Amdur R.J., and Mendenhall W.M. Definitive radiotherapy for head-and-neck cancer with radiographical retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure. Int J Radiat Oncol Biol Phys 66 (2006) 1017-1021
70. Ware R.E., Matthews J.P., Hicks R.J., et al. Usefulness of fluorine-18flurodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for SCC of the head and neck. Head Neck 26 (2004) 1008-1017
71. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG-PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
72. Ong S.C., Schöder H., Lee N.Y., et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. J Nucl Med 49 (2008) 532-540
73. Andrade R.S., Heron D.E., Degirmenci B., et al. Post treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1315-1322
74. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [18F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
75. Greven K.M., Williams D.W., McGuirt W.F., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
76. Hollenbeak C.S., Lowe V.J., and Stack Jr. B.C. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck. Cancer 92 (2001) 2341-2348
77. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Cost-effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359 (2002) 1388-1393
78. Nguyen V.H., Peloquin S., and Lacasse Y. Cost-effectiveness of positron emission tomography for the management of non-small cell lung cancer in Quebec. Can Respir J 12 (2005) 19-25